Design and synthesis of a minimal bacterial genome CA Hutchison III, RY Chuang, VN Noskov, N Assad-Garcia, TJ Deerinck, ... Science 351 (6280), aad6253, 2016 | 1479 | 2016 |
Horizontal gene transfer of the algal nuclear gene psbO to the photosynthetic sea slug Elysia chlorotica ME Rumpho, JM Worful, J Lee, K Kannan, MS Tyler, D Bhattacharya, ... Proceedings of the National Academy of Sciences 105 (46), 17867-17871, 2008 | 308 | 2008 |
The general mode of translation inhibition by macrolide antibiotics K Kannan, P Kanabar, D Schryer, T Florin, E Oh, N Bahroos, T Tenson, ... Proceedings of the National Academy of Sciences 111 (45), 15958-15963, 2014 | 197 | 2014 |
The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide N Vázquez‐Laslop, H Ramu, D Klepacki, K Kannan, AS Mankin The EMBO journal 29 (18), 3108-3117, 2010 | 172 | 2010 |
Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel K Kannan, N Vázquez-Laslop, AS Mankin Cell 151 (3), 508-520, 2012 | 167 | 2012 |
Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center J Marks, K Kannan, EJ Roncase, D Klepacki, A Kefi, C Orelle, ... Proceedings of the National Academy of Sciences 113 (43), 12150-12155, 2016 | 158 | 2016 |
Macrolide antibiotics in the ribosome exit tunnel: species‐specific binding and action K Kannan, AS Mankin Annals of the New York Academy of Sciences 1241 (1), 33-47, 2011 | 137 | 2011 |
Digital-to-biological converter for on-demand production of biologics KS Boles, K Kannan, J Gill, M Felderman, H Gouvis, B Hubby, KI Kamrud, ... Nature biotechnology 35 (7), 672-675, 2017 | 93 | 2017 |
Regulation of gene expression by macrolide-induced ribosomal frameshifting P Gupta, K Kannan, AS Mankin, N Vázquez-Laslop Molecular cell 52 (5), 629-642, 2013 | 74 | 2013 |
Cloning, assembly, and modification of the primary human cytomegalovirus isolate Toledo by yeast-based transformation-associated recombination S Vashee, TB Stockwell, N Alperovich, EA Denisova, DG Gibson, ... Msphere 2 (5), 10.1128/mspheredirect. 00331-17, 2017 | 44 | 2017 |
Yeast genome, by design K Kannan, DG Gibson Science 355 (6329), 1024-1025, 2017 | 27 | 2017 |
One step engineering of the small-subunit ribosomal RNA using CRISPR/Cas9 K Kannan, B Tsvetanova, RY Chuang, VN Noskov, N Assad-Garcia, L Ma, ... Scientific reports 6 (1), 30714, 2016 | 22 | 2016 |
Design and synthesis of a minimal bacterial genome EA Strychalski, CA Hutchinson III, RY Chuang, V Noskov, N Assad-Garcia, ... Elizabeth A. Strychalski, Clyde A. Hutchinson III, Ray-Yuan Chuang, Vladimir …, 2016 | 13 | 2016 |
Polypeptides with type v crispr activity and uses thereof RD Monds, SM Mantovani, RS Komor, MC LaFave, K Kannan, ... US Patent App. 15/953,286, 2018 | 10 | 2018 |
Tannase activity from the marine cyanobacterium Phormidium valderianum BDU140441 S Palanisami, K Kannan, U Lakshmanan Journal of applied phycology 24, 1093-1098, 2012 | 8 | 2012 |
Generation of synthetic genomes CA Hutchison III, RY Chuang, VN Noskov, BJ Karas, KS Wise, HO Smith, ... US Patent 11,085,037, 2021 | 2 | 2021 |
Gross Chromosomal Rearrangements in Kluyveromyces marxianus Revealed by Illumina and Oxford Nanopore Sequencing L Ding, HD Macdonald, HO Smith, CA Hutchison III, C Merryman, ... International journal of molecular sciences 21 (19), 7112, 2020 | | 2020 |
Printing Biologics on Demand K Kannan, KS Boles, DG Gibson CELL SYSTEMS 5 (1), 5-5, 2017 | | 2017 |
Context‐specific action of linezolid and chloramphenicol, the inhibitors of ribosomal peptidyl transferase (752.12) J Marks, C Orelle, K Kannan, D Klepacki, E Roncase, N Vazquez‐Laslop, ... The FASEB Journal 28, 752.12, 2014 | | 2014 |
The Novel Modes of Action of Ribosomal Antibiotics K Kannan University of Illinois at Chicago, 2013 | | 2013 |